These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding. Al-Tamimi M; Mu FT; Arthur JF; Shen Y; Moroi M; Berndt MC; Andrews RK; Gardiner EE Platelets; 2009 Mar; 20(2):75-82. PubMed ID: 19235048 [TBL] [Abstract][Full Text] [Related]
3. Fc gamma receptor-mediated interplatelet activation by a monoclonal antibody against beta 2 microglobulin. Rubinstein E; Boucheix C; Urso I; Carroll RC J Immunol; 1991 Nov; 147(9):3040-6. PubMed ID: 1833461 [TBL] [Abstract][Full Text] [Related]
4. Characterization of platelet activation induced by HLA antibodies associated with alloimmune thrombocytopenia. Christie DJ; Leja DN; Carlson DL; Swinehart CD J Lab Clin Med; 1993 Mar; 121(3):437-43. PubMed ID: 7680369 [TBL] [Abstract][Full Text] [Related]
5. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor. Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505 [TBL] [Abstract][Full Text] [Related]
6. Fc gamma II receptor-mediated platelet activation induced by anti-CD9 monoclonal antibody opens Ca2+ channels which are distinct from those associated with Ca2+ store depletion. Kuroda K; Ozaki Y; Qi R; Asazuma N; Yatomi Y; Satoh K; Nomura S; Suzuki M; Kume S J Immunol; 1995 Nov; 155(9):4427-36. PubMed ID: 7594604 [TBL] [Abstract][Full Text] [Related]
8. Platelet pro-aggregatory effects of CD40L monoclonal antibody. Mirabet M; Barrabés JA; Quiroga A; Garcia-Dorado D Mol Immunol; 2008 Feb; 45(4):937-44. PubMed ID: 17959249 [TBL] [Abstract][Full Text] [Related]
9. Off-target platelet activation in macaques unique to a therapeutic monoclonal antibody. Santostefano MJ; Kirchner J; Vissinga C; Fort M; Lear S; Pan WJ; Prince PJ; Hensley KM; Tran D; Rock D; Vargas HM; Narayanan P; Jawando R; Rees W; Reindel JF; Reynhardt K; Everds N Toxicol Pathol; 2012 Aug; 40(6):899-917. PubMed ID: 22552394 [TBL] [Abstract][Full Text] [Related]
10. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein. Shido K; Ahmad G; Hsu L; Kamiyama M J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587 [TBL] [Abstract][Full Text] [Related]
11. [Inhibition of thrombocyte aggregation by F(ab')2-fragments of monoclonal antibodies FraMon (CRC64) to glycoproteins IIb-IIIa]. Mazurov AV; Pevzner DV; Khaspekova SG; Dudnik OA; Byzova TV; Vlasik TN; Bakharev VN; Pistsov MIu; Staroverov II; Ruda MIa Ter Arkh; 2001; 73(9):66-73. PubMed ID: 11642086 [TBL] [Abstract][Full Text] [Related]
12. Flow cytometric observations on the in vivo use of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb-IIIa. Christopoulos C; Mackie I; Lahiri A; Machin S Blood Coagul Fibrinolysis; 1993 Oct; 4(5):729-37. PubMed ID: 8292722 [TBL] [Abstract][Full Text] [Related]
13. [Identification of human platelet specific functional antibody and its fragments]. Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061 [TBL] [Abstract][Full Text] [Related]
14. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa. Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012 [TBL] [Abstract][Full Text] [Related]
15. Neutrophil activation by anti-beta 2 glycoprotein I monoclonal antibodies via Fc gamma receptor II. Arvieux J; Jacob MC; Roussel B; Bensa JC; Colomb MG J Leukoc Biol; 1995 Mar; 57(3):387-94. PubMed ID: 7884309 [TBL] [Abstract][Full Text] [Related]
16. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets. Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345 [TBL] [Abstract][Full Text] [Related]
17. Effects of beta2-glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditions. Font J; Espinosa G; Tàssies D; Pino M; Khamashta MA; Gallart T; Cervera R; Escolar G; Hughes GR; Ingelmo M; Ordinas A; Reverter JC Arthritis Rheum; 2002 Dec; 46(12):3283-9. PubMed ID: 12483733 [TBL] [Abstract][Full Text] [Related]
18. Adenosine diphosphate-induced aggregation of human platelets in flow through tubes: III. Shear and extrinsic fibrinogen-dependent effects. Goldsmith HL; Frojmovic MM; Braovac S; McIntosh F; Wong T Thromb Haemost; 1994 Jan; 71(1):78-90. PubMed ID: 8165650 [TBL] [Abstract][Full Text] [Related]
19. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity. Lackner KJ; von Landenberg C; Barlage S; Schmitz G Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321 [TBL] [Abstract][Full Text] [Related]
20. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids. Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]